Peptide Sequence Mapping around Bisecting GlcNAc-Bearing <em>N</em>-Glycans in Mouse Brain

<i>N</i>-glycosylation is essential for many biological processes in mammals. A variety of <i>N</i>-glycan structures exist, of which, the formation of bisecting <i>N</i>-acetylglucosamine (GlcNAc) is catalyzed by <i>N</i>-acetylglucosaminyltransferase...

Full description

Bibliographic Details
Main Authors: Yuki Ohkawa, Yasuhiko Kizuka, Misaki Takata, Miyako Nakano, Emi Ito, Sushil K. Mishra, Haruna Akatsuka, Yoichiro Harada, Naoyuki Taniguchi
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/16/8579
Description
Summary:<i>N</i>-glycosylation is essential for many biological processes in mammals. A variety of <i>N</i>-glycan structures exist, of which, the formation of bisecting <i>N</i>-acetylglucosamine (GlcNAc) is catalyzed by <i>N</i>-acetylglucosaminyltransferase-III (GnT-III, encoded by the <i>Mgat3</i> gene). We previously identified various bisecting GlcNAc-modified proteins involved in Alzheimer’s disease and cancer. However, the mechanisms by which GnT-III acts on the target proteins are unknown. Here, we performed comparative glycoproteomic analyses using brain membranes of wild type (WT) and <i>Mgat3</i>-deficient mice. Target glycoproteins of GnT-III were enriched with E4-phytohemagglutinin (PHA) lectin, which recognizes bisecting GlcNAc, and analyzed by liquid chromatograph-mass spectrometry. We identified 32 <i>N</i>-glycosylation sites (Asn-Xaa-Ser/Thr, Xaa ≠ Pro) that were modified with bisecting GlcNAc. Sequence alignment of identified <i>N</i>-glycosylation sites that displayed bisecting GlcNAc suggested that GnT-III does not recognize a specific primary amino acid sequence. The molecular modeling of GluA1 as one of the good cell surface substrates for GnT-III in the brain, indicated that GnT-III acts on <i>N</i>-glycosylation sites located in a highly flexible and mobile loop of GluA1. These results suggest that the action of GnT-III is partially affected by the tertiary structure of target proteins, which can accommodate bisecting GlcNAc that generates a bulky flipped-back conformation of the modified glycans.
ISSN:1661-6596
1422-0067